This program project deals with myelination, demyelination, and remyelination as it pertains to multiple sclerosis (MS). Project 1 is concerned with immunocyte function (particularly that of T suppressor cells and monocytes) in MS and how it can be manipulated so as to favorably influence the course of the disease. Suppressor function is decreased when MS is active, whereas monocyte function is increased. Emphasis is placed on beta2-adrenergic and muscarinic cholinergic receptors on lymphocytes and monocytes and their role in cell function. Both classes of receptor are up-regulated on immunocytes in progressive MS. Project 2 deals with proteoglycans and glycoproteins synthesized by oligodendrocyte known as OMgp which has been cloned and sequenced. The function of OMgp remains to be determined and is a major goal of Project 3. There is reason to believe, based on its structure, that OMgp will prove to be an adhesion molecule. Project 4 is directed towards Theiler's virus-induced demyelination as a model for the demyelination that characterized MS. The goal is to establish the determinants on Theiler's virus responsible for demyelination using molecular biologic techniques. The entire genome of three strains of Theiler's virus has been sequenced which should facilitate this task. Project 6 is directed to a study of the effects of cytokines on ion channels in sympathetic neurons. There are extensive interactions between the various projects and the two cores - Core A administrative and Core B scientific. The latter provides patient and control samples to the various projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS024575-06
Application #
3100149
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Project Start
1988-04-01
Project End
1996-03-30
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Jensen, M A; Dayal, A; Arnason, B G (1999) Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis. J Autoimmun 12:73-80
Qu, Z X; Dayal, A; Jensen, M A et al. (1998) All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol 55:315-21
Chelmicka-Schorr, E; Wiegmann, K; Wollmann, R et al. (1998) Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. J Autoimmun 11:329-34
Takeda, M; Soliven, B (1997) Arachidonic acid inhibits myelin basic protein phosphorylation in cultured oligodendrocytes. Glia 21:277-84
Arnason, B G; Toscas, A; Dayal, A et al. (1997) Role of interferons in demyelinating diseases. J Neural Transm Suppl 49:117-23
Attali, B; Wang, N; Kolot, A et al. (1997) Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J Neurosci 17:8234-45
Lee, T E; Philipson, L H; Nelson, D J (1996) N-type inactivation in the mammalian Shaker K+ channel Kv1.4. J Membr Biol 151:225-35
Pliskin, N H; Hamer, D P; Goldstein, D S et al. (1996) Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 47:1463-8
Arnason, B G (1996) Interferon beta in multiple sclerosis. Clin Immunol Immunopathol 81:1-11
Jensen, M A; Arnason, B G; Toscas, A et al. (1996) Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis. J Autoimmun 9:587-97

Showing the most recent 10 out of 58 publications